Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia.

摘要

In a given year, approximately 2.4 million American adults, or about 1.1% of the population 18 years of age and older, have schizophrenia. Men and women are affected with equal frequency. A severe, chronic brain disorder, schizophrenia is characterized by an onset in early adulthood, a lifelong course, debilitating symptoms, deterioration in functional ability, and lack of social acceptability, making it among the most disabling, and economically catastrophic disorders. Symptoms appear in men in their late teens or early 20s, whereas women are generally affected in their 20s or early 30s. In the U.S., annual direct and indirect costs of the disorder total more than dollar62 billion.